Stay updated with breaking news from Concorde Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Post the earnings, brokerage Citi is overweight on PSU Utilities & Defence, Industrials, Banks/Insurance and underweight on Consumer Discretionary, IT Services, and Metals. Its December 2024 NIFTY target is 22.5k, which indicates a 2 percent upside.
In May 2021, in a move to improve operational efficiency, Aurobindo Pharma had approved the transfer of its injectable assets into a subsidiary called Eugia Pharma Specialities Limited for “greater focus, attention and specialization” and also to “augment fund-raise and strategic tie-ups in future through joint ventures etc
Markets continued to drift downwards and lost ground once again on a weekly basis. They lost on two of the four trading sessions of the truncated week which had Independence Day as the holiday.At the end of it all, BSESENSEX lost 373.99 points ...
Markets in the week gone by were choppy and volatile. They gained on two of the five trading sessions and lost on three. Mount 20K on NIFTY is looking like an uphill task and markets are just not able to gather enough steam to put in the thrust ...
Markets were under pressure last week but made a sharp recovery on Friday and completed a decent rearguard action from the lows made on Thursday. Unfortunately, the US markets which were going great guns on Friday, did a U-turn and after being ...